Atexakin (which is IL6) is apparently about to enter a Phase II clinical trial in early 2017.
There is more on this here; Clinical Trials | Relief Therapeutics. |
All times are GMT -5. The time now is 10:53 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.